Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Meds A-Z

Cefovecin

Detailed information about Cefovecin

Official label facts Owner quick guide first Marketing clearly labeled
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Reviewed / Updated / Sources

Reviewed: Not available

Updated: February 12, 2026, 10:44 PM UTC

Sources:

Pet Owner Quick Guide

Start here first for the simple next-step summary.

Used for:

For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

What to watch for:

  • For subcutaneous use in dogs and cats only
  • Maximum treatment should not exceed 2 injections
  • Vomiting (1 reports)
  • Increased percentage reticulocytes (1 reports)
  • Inappetence (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Safety & side effects

What to watch:

  • For subcutaneous use in dogs and cats only
  • Maximum treatment should not exceed 2 injections
  • Vomiting
  • Increased percentage reticulocytes
  • Inappetence

Most reported reactions:

  • Vomiting (1 reports)
  • Increased percentage reticulocytes (1 reports)
  • Inappetence (1 reports)

When to call your vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Data freshness: source data appears current.

Latest refresh: Mar 21, 2026, 10:02 a.m.

Data freshness
  • Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 17, 2026, 11:06 AM UTC
Image coming soon
Cefovecin

Cefovecin

Drug type: Generic ingredient • Branded profile • FDA branded products available

Species: Both

Manufacturer: Not available (source)

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Not available
Form: Lyophilized powder for injection, Powder
Identifiers:
ANADA: 200812 NADA: 141285 NDC Package: 17033-002-01 NDC Package: 54771-1520-1 NDC Product: 17033 NDC Product: 54771
Source metadata:

Warnings / Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

  • High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
31
Species represented
2
Grouped by Body System
Digestive (4) · Vomiting, Drooling, Diarrhea Other (28) · Increased percentage reticulocytes, Inappetence, Immune-mediated polyarthropathy
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Digestive 1 Cat 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Cat 1
Other 1 Dog 1
Other 1 Dog 1

Species coverage: Dog (20) Cat (12)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Digestive Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Digestive Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Digestive Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Digestive Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Source metadata:

Documents

Owner handouts and official technical documents are grouped for faster access.

Owner handouts (0)
  • No owner handouts linked yet.
Official label / PI (0)
  • No official label or package insert links yet.
SPL (2)
  • Cefovecin Sodium for Injection · SPL
    https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17466/Cefovecin%20Sodium%20for%20Injection
  • Convenia® · SPL
    https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/171/Convenia%C2%AE
FOI (2)
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 17, 2026, 11:06 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Cefovecin Sodium for Injection Convenia®
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Cat, Dog
Rx/OTC: RX
Form/route: Lyophilized powder for injection, Powder • Subcutaneous
Applications: ANADA 200-812 • NADA 141-285
Documents: 2 (FOI: 2) • SPL: 2 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 22 • Cat 26 • View
Case summaries: 11 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only. (Contraindication, High)
Top reaction signals
Vomiting (1) Increased percentage reticulocytes (1) Inappetence (1) Immune-mediated polyarthropathy (1) Immune mediated haemolytic anaemia (1) Hiding (1) Glomerulonephritis (1) Fever (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200812 NADA: 141285 NDC Package: 17033-002-01 NDC Package: 54771-1520-1 NDC Product: 17033 NDC Product: 54771
Package NDC Product NDC Form / Route Status
17033-002-01 17033 -
54771-1520-1 54771 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 5 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this dr… (Official, 2026-02-12)
  • side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Death, Anorexia, Diarrhoea, Not eating. (Official, 2026-02-12)
  • usage: For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infectio… (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Cefovecin Sodium for Injection
RX
Cefovecin sodium
Lyophilized powder for injection • Subcutaneous
Label highlights
Official documents
Qilu Animal Health Products Co., Ltd. ANADA 200-812 Approved Jul 1, 2025
Convenia®
RX
Cefovecin sodium
Powder • Subcutaneous
Label highlights
Official documents
Zoetis Inc. NADA 141-285 Approved Oct 2, 2017

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications
Each mL of reconstituted lyophile contains 80 mg of cefovecin as the sodium salt
Dogs
Indication

For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Dosage

Administer 3.6 mg/pound (lb) (8 mg/kilograms (kg)) body weight as a single subcutaneous injection. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete.

Limitations
Cats
Indication

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

Dosage

Administer 3.6 mg/lb (8 mg/kg) body weight as a single, one-time subcutaneous injection.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of constituted solution contains 80 milligrams cefovecin as the sodium salt.
Cats
Indication
For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
Dosage
Administer 3.6 mg/lb (8 mg/kg) body weight as a single, one-time subcutaneous injection.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only.
Dogs
Indication
For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Dosage
Administer 3.6 mg/lb (8 mg/kg) body weight as a single subcutaneous injection. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

Documents
  • Summary

    Dogs: For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

    Cats: For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

SPL Packages

FDA page: Open in Animal Drugs @ FDA

Documents
  • Summary
    For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Usage

For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Vomiting (1) • Cat Drooling (1) • Cat Diarrhea (1) • Dog Blood in vomit (1) • Cat

Showing top 5 for Digestive.

Other
Increased percentage reticulocytes (1) • Dog Inappetence (1) • Cat Immune-mediated polyarthropathy (1) • Dog Immune mediated haemolytic anaemia (1) • Dog Hiding (1) • Cat
Show more (23)
Glomerulonephritis (1) • Dog Fever (1) • Dog Elevated total bilirubin (1) • Dog Elevated protein:creatinine ratio (1) • Dog Elevated liver enzymes NOS (1) • Dog Discomfort NOS (1) • Cat Dilated pupils (1) • Cat Difficulty to rise (1) • Dog Dermatitis (1) • Dog Dermal nodule (1) • Dog Dehiscence (1) • Dog Decreased haematocrit (1) • Dog Death by euthanasia (1) • Dog Death (1) • Dog Cellulitis (1) • Dog Carcinoma NOS (1) • Cat Blood in urine (1) • Cat Autoimmune disorder NOS (1) • Dog Anaphylaxis (1) • Cat Anal sac disorder (1) • Dog Abscess NOS (1) • Dog Abnormal ultrasound finding (1) • Cat Abnormal cytology (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Snowshoe, Male, 1 year, 4.264 kilogram • Drug: MSK, Subcutaneous, Dose: 0.40 mL per animal • Reactions: Vomiting, Blood in vomit, Death, Anaphylaxis • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-055626
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 1.00 Year
  • Weight: 4.264 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Dose: 0.40 mL per animal
Reactions Reported:
Vomiting Blood in vomit Death Anaphylaxis
Outcomes: Died

Cat, Domestic Shorthair, Male, 2 year, 4.35 kilogram • Drug: MSK, Injection, Unknown • Reactions: Partial lack of efficacy, Medication error NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-054729
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 2.00 Year
  • Weight: 4.350 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Injection
Reactions Reported:
Partial lack of efficacy Medication error NOS
Outcomes: Ongoing

Cat, Domestic Longhair, Female, 17 year, 3.97 kilogram • Drug: MSK, Injection, Unknown • Reactions: Lack of efficacy - NOS, Blood in urine, Urine abnormalities NOS, Abnormal ultrasound finding, Abnormal cytology… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-054722
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 17.00 Year
  • Weight: 3.970 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Injection
Reactions Reported:
Lack of efficacy - NOS Blood in urine Urine abnormalities NOS Abnormal ultrasound finding Abnormal cytology Carcinoma NOS Intentional misuse Discomfort NOS
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 12 year, 2.948 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 0.30 mL per animal • Reactions: Hiding, Wobbliness, Dilated pupils, Nasal discharge, Death… • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-054748
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 12.00 Year
  • Weight: 2.948 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection
  • Dose: 0.30 mL per animal
Reactions Reported:
Hiding Wobbliness Dilated pupils Nasal discharge Death Drooling Intentional misuse
Outcomes: Died

Cat, Domestic Shorthair, Female, 16 year, 4.7 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 0.48 mL per animal • Reactions: Inappetence, Vomiting, Tiredness (lethargy), Hiding, Diarrhea • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-054740
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 16.00 Year
  • Weight: 4.700 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection
  • Dose: 0.48 mL per animal
Reactions Reported:
Inappetence Vomiting Tiredness (lethargy) Hiding Diarrhea
Outcomes: Ongoing

Dog, Shepherd Dog - Australian, Male, 6 year, 17.872 kilogram • Drug: MSK, Subcutaneous, Dose: 2.20 mL per animal • Reactions: Abscess NOS, Dehiscence, Dermatitis, Pain NOS, Fever… • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-055651
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 6.00 Year
  • Weight: 17.872 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Dose: 2.20 mL per animal
Reactions Reported:
Abscess NOS Dehiscence Dermatitis Pain NOS Fever Cellulitis Skin necrosis Steatitis Panniculitis Skin abscess Immune-mediated polyarthropathy Decreased haematocrit Immune mediated haemolytic anaemia Autoimmune disorder NOS Elevated protein:creatinine ratio Glomerulonephritis Elevated total bilirubin Elevated liver enzymes NOS Diarrhea Increased percentage reticulocytes Death by euthanasia
Outcomes: Euthanized

Dog, Chihuahua, Female, 11 year, 3.629 kilogram • Drug: MSK, Injection, Subcutaneous • Reactions: Paralysis NOS, Death, Unable to walk • Outcome: Died

  • Report ID: USA-USFDACVM-2025-US-055109
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Female
  • Age: 11.00 Year
  • Weight: 3.629 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection
Reactions Reported:
Paralysis NOS Death Unable to walk
Outcomes: Died

Dog, Siberian Husky, Female, 8.1 year, 26.85 kilogram • Drug: MSK, Injection, solution, Subcutaneous • Reactions: Difficulty to rise, Skin lesion NOS, Skin scab, Increased skin sensitivity • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055654
  • Serious AE: No
  • Treated For AE: No
  • Sex: Female
  • Age: 8.10 Year
  • Weight: 26.850 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection, solution
Reactions Reported:
Difficulty to rise Skin lesion NOS Skin scab Increased skin sensitivity
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.